NHS Framework for the Midlands and East, Branded Medicines – Tranche B plus Cytokine Modulators and other Monoclonal Antibodies.

The NHS Commissioning Board (operating under the name of NHS England)contractFind a Tender ↗Ref ocds-h6vhtk-02956532014L0024active

Estimated value

—

goods

Awarded value

—

Suppliers

56

15 SME

Lots

4

18 awarded

Published

23 Feb 2021

Other contracts from The NHS Commissioning Board (operating under the name of NHS England)· 10

Most recent notices published by the same contracting authority.

View buyer profile →

Title	Type	Value	Published
PMO support for the Cancer Healthcare and AI in Health and Care Programmes	call off	£1.4m	28 Apr 2023
NHS England & Improvement South West - Provision of Health Care Services to Vinney Green Secure Children’s Home	contract	£5.2m	13 May 2022
Implementation of GP referral pathway to NHS CPCS	contract	—	12 May 2022
NHS England and NHS Improvement - Independent Clinical Reviews into Deaths in Custody – South East Health & Justice, Detained Estates	contract	—	29 Apr 2022
Provision of Benchmarking Performance Against the Learning Disability Improvement Standards for NHS Trusts	contract	£800k	18 Mar 2022
NHS National Pharmaceuticals Transition 2022_1	contract	£468.0m	17 Mar 2022
National Patient Safety Improvement Programmes Measurement Support	contract	£750k	16 Mar 2022
NHS South of England Branded Medicines - Tranche B and Annual	contract	£875.7m	08 Mar 2022
Invitation to offer for NHS London Branded Medicines - Tranche A and Annual	contract	£276.5m	08 Mar 2022
NHS Framework Agreement for the supply of Medical Retinal Vascular Treatments	contract	£450.0m	07 Mar 2022

Other contracts awarded to Accord-UK Ltd· 10

Cross-buyer view of this supplier's public-sector wins.

View supplier profile →

Title	Type	Value	Published
NHS National Generics Pharmaceuticals - Supply Chain Resilience	contract	—	01 May 2026
NHS National Branded Interim - 1 June 2026	contract	—	16 Apr 2026
NHS Generic Pharmaceuticals - Lenalidomide, Pomalidomide & Thalidomide	contract	—	26 Mar 2026
Generic Drugs – Injections/Infusions 2	contract	—	03 Mar 2026
NHS National Framework for Transition Products (Nintedanib and Dalbavancin)	contract	—	25 Feb 2026
Transitional Drugs 6	contract	—	04 Feb 2026
NHS National Generic Pharmaceuticals - Wave 15c	contract	—	14 Jan 2026
NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin	contract	—	26 Nov 2025
NHS National Framework for Generics Housekeeping	contract	—	11 Nov 2025
Project/Contract NHS National Framework for Denosumab Injection	contract	—	02 Oct 2025